Thomas McCourt
Vorstandsvorsitzender bei IRONWOOD PHARMACEUTICALS, INC.
Vermögen: 10 Mio $ am 30.04.2024
Aktive Positionen von Thomas McCourt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IRONWOOD PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 04.06.2021 | - |
Vorstandsvorsitzender | 12.03.2021 | - | |
Präsident | 01.04.2019 | - | |
Vertrieb & Marketing | 01.01.2009 | 01.04.2019 | |
PLIANT THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 06.03.2023 | - |
Independent Dir/Board Member | 06.03.2023 | - | |
American Society for Gastrointestinal Endoscopy | Direktor/Vorstandsmitglied | 01.05.2009 | - |
Karriereverlauf von Thomas McCourt
Ehemalige bekannte Positionen von Thomas McCourt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACCELERON PHARMA INC. | Direktor/Vorstandsmitglied | 25.07.2016 | 19.11.2021 |
Independent Dir/Board Member | 25.07.2016 | 19.11.2021 | |
NOVARTIS AG | Vertrieb & Marketing | 01.01.2001 | 01.01.2008 |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Gründer | 01.04.1992 | 01.06.1999 |
Corporate Officer/Principal | 01.04.1992 | 01.06.1999 |
Ausbildung von Thomas McCourt
University of Wisconsin | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Schweiz | 2 |
Operativ
Director/Board Member | 4 |
Sales & Marketing | 2 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
NOVARTIS AG | Health Technology |
PLIANT THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
American Society for Gastrointestinal Endoscopy |
- Börse
- Insiders
- Thomas McCourt
- Erfahrung